↓ Skip to main content

RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer

Overview of attention for article published in Journal of Translational Medicine, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
7 X users
patent
1 patent

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
35 Mendeley
Title
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
Published in
Journal of Translational Medicine, April 2019
DOI 10.1186/s12967-019-1878-3
Pubmed ID
Authors

Aruz Mesci, Fabrice Lucien, Xiaoyong Huang, Eric H. Wang, David Shin, Michelle Meringer, Christianne Hoey, Jessica Ray, Paul C. Boutros, Hon S. Leong, Stanley K. Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 29%
Student > Bachelor 3 9%
Student > Master 3 9%
Researcher 3 9%
Professor > Associate Professor 2 6%
Other 4 11%
Unknown 10 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 23%
Medicine and Dentistry 5 14%
Agricultural and Biological Sciences 3 9%
Engineering 2 6%
Chemistry 2 6%
Other 5 14%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#4,183,342
of 23,142,049 outputs
Outputs from Journal of Translational Medicine
#677
of 4,067 outputs
Outputs of similar age
#87,070
of 350,948 outputs
Outputs of similar age from Journal of Translational Medicine
#19
of 109 outputs
Altmetric has tracked 23,142,049 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,067 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,948 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.